Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health CatalystHCAT +2.03%55 1-Year Share Buyback Ratio is -5.30 as of Jun. 2026. GuruFocus rates HCAT with a GF Score™ of 55/100 and a GF Value™ of $4.27 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 392 Healthcare Providers & Services companies, Health Catalyst ranks worse than 66.07% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Health Catalyst's current 1-Year Share Buyback Ratio was -5.30%.
HCAT's 1-Year Share Buyback Ratio is ranked worse than 66.07% of 392
companies
in the Healthcare Providers & Services industry
Industry Median: -1
vs HCAT: -5.30
Health Catalyst (NAS:HCAT) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Health Catalyst 1-Year Share Buyback Ratio Related Terms
HCAT vs LFMD, AMWL, OPRX: 1-Year Share Buyback Ratio Comparison
For the Health Information Services subindustry, Health Catalyst's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst 1-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Health Catalyst's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of -5.30 mean?
Health Catalyst (HCAT) has a 1-Year Share Buyback Ratio of -5.30 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Health Catalyst and its competitors. According to the industry distribution chart, Health Catalyst ranks #259 out of 392 companies in the Healthcare Providers & Services industry, placing it in the top 66.1%.
Is Health Catalyst's 1-Year Share Buyback Ratio too high?
Health Catalyst's current 1-Year Share Buyback Ratio is -5.30. Based on the distribution chart, Health Catalyst ranks #259 out of 392 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Health Catalyst has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's 1-Year Share Buyback Ratio compare to LFMD and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #259 out of 392 companies for 1-Year Share Buyback Ratio. This places Health Catalyst in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 1-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Health Catalyst and its competitors. Health Catalyst's current 1-Year Share Buyback Ratio is -5.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $4.27, compared to a current price of $1.77 — trading 58.7% below its estimated fair value. The current 1-Year Share Buyback Ratio is -5.30. Health Catalyst's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Health Catalyst (HCAT), the current 1-Year Share Buyback Ratio is -5.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $1.77 is trading 58.7% below its estimated GF Value™ of $4.27.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
1-Year Share Buyback Ratio: -5.30
GF Value™: $4.27 vs. price of $1.77 (58.7% below fair value)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
55GF Score
Get the complete analysis for HCAT
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
